Loss of response to scheduled infliximab therapy for Crohn's disease in adults: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Loss of response to scheduled infliximab therapy for Crohn's disease in adults: A systematic review and meta‐analysis

Published:2019-02 Issue:2 Volume:20 Page:65-72
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J Dig Dis

Author:

Zhang Qi Wei¹^ORCID,Shen Jun¹,Zheng Qing¹,Ran Zhi Hua¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology, Ministry of Health Inflammatory Bowel Disease Research Center, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12698

Reference42 articles.

1. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

2. Review article: infliximab therapy for inflammatory bowel disease - seven years on

3. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease